Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

386
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
386
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

2.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consumer Engagement in Chronic Conditions Research: An Integrated Framework Informed by Recognition Theory.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Measuring Fatigue in Multiple Sclerosis: A Rapid Review.

The patient·2025
Same author

Disentangling Blood-Based Markers of Multiple Sclerosis Through Machine Learning: An Evaluation Study.

Studies in health technology and informatics·2025
Same author

Co-Designing a Multiple Sclerosis Fatigue App.

Studies in health technology and informatics·2025
Same author

Supporting consumer engagement in health research about chronic conditions: a scoping review of evidence-based resources.

Research involvement and engagement·2025
Same author

Metal Oxide-Metal Organic Framework Layers for Discrimination of Multiple Gases Employing Machine Learning Algorithms.

ACS applied materials & interfaces·2025
Same journal

A GenAI Pipeline for Violinist Kinematic Data Management.

Studies in health technology and informatics·2026
Same journal

AMAL-For-Qatar: A Comprehensive AI Ecosystem for Fetal Ultrasound Analysis - Project Overview and Achievements.

Studies in health technology and informatics·2026
Same journal

Longitudinal Treatment-Aware Multimodal AI for Dermatology: A Scoping Review.

Studies in health technology and informatics·2026
Same journal

Predicting Postpartum Depression Using Imbalance-Aware Machine Learning.

Studies in health technology and informatics·2026
Same journal

Validation of Deep-Learning Models for Autosegmentation of Brain Metastases.

Studies in health technology and informatics·2026
Same journal

Delay-Dependent Gating in Modular RNNs.

Studies in health technology and informatics·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

94.8K

Comparing Deterministic and Stochastic Reinforcement Learning for Glucose Regulation in Type 1 Diabetes.

David Timms1, Chirath Hettiarachchi1, Hanna Suominen1,2

  • 1The Australian National University, Australia.

Studies in Health Technology and Informatics
|August 8, 2025
PubMed
Summary
This summary is machine-generated.

Reinforcement Learning (RL) algorithms show promise for autonomous Artificial Pancreas Systems (APS) in Type 1 Diabetes (T1D) management. Stochastic algorithms like PPO generally outperformed deterministic TD3, though interpretability remains a challenge for both.

Keywords:
Artificial PancreasDeep LearningEvaluation StudyType 1 Diabetes

More Related Videos

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

6.0K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K

Related Experiment Videos

Last Updated: Sep 12, 2025

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

94.8K
Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

6.0K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.7K

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Endocrinology

Background:

  • Type 1 Diabetes (T1D) necessitates continuous glucose monitoring and insulin therapy.
  • Current Artificial Pancreas Systems (APS) require manual input, posing a cognitive burden.
  • Reinforcement Learning (RL) offers a potential solution for autonomous glucose regulation in APS.

Purpose of the Study:

  • To compare the efficacy of stochastic (PPO) and deterministic (TD3) RL algorithms for glucose regulation in silico.
  • To evaluate RL algorithm performance using quantitative, qualitative, and patient-specific metrics.
  • To assess the safety and suitability of different RL approaches for APS.

Main Methods:

  • In silico evaluation using the UVA/PADOVA 2008 T1D simulator.
  • Comparison of Proximal Policy Optimization (PPO) and Twin Delayed Deep Deterministic Policy Gradient (TD3) algorithms.
  • Utilized quantitative metrics, qualitative assessments, and patient-specific clinical data.

Main Results:

  • Both PPO and TD3 demonstrated potential for autonomous glucose regulation.
  • PPO generally showed superior performance compared to TD3 in the simulations.
  • TD3 exhibited more interpretable behavior, but this did not consistently correlate with better outcomes.

Conclusions:

  • RL algorithms hold promise for reducing the burden of T1D management via APS.
  • Further research is needed to enhance the interpretability and predictive performance of RL algorithms in APS.
  • Algorithm selection requires careful consideration of both performance and safety/interpretability.